The role of alveolar macrophages in the pathogenesis of recurrent airway obstruction in horses

Journal of Veterinary Internal Medicine

Volumn 20, Issue 1, 2006, Pages 167-174

  Laan, Tamarinde T J M ^a,d,e   Bull, Sarah ^a,b   Pirie, R ^c   Fink Gremmels, Johanna ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d Veterinary Clinic DeLingehoeve   (Netherlands)

^e NONE   (Netherlands)

Author keywords

Aerosolized challenges; Aspergillus fumigatus; Cytokine expression; Hay dust solution; Heaves; Lipopolysaccharide

Indexed keywords

CYTOKINE; FUNGUS ANTIGEN; LIPOPOLYSACCHARIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ASPERGILLUS FUMIGATUS; CHEMICALLY INDUCED DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOLOGY; DUST; FEMALE; GENE EXPRESSION REGULATION; HORSE; HORSE DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIGENS, FUNGAL; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DUST; FEMALE; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; LIPOPOLYSACCHARIDES; LUNG DISEASES, OBSTRUCTIVE; MACROPHAGES, ALVEOLAR; MALE;

ASPERGILLUS FUMIGATUS; EQUIDAE; EQUUS CABALLUS;

EID: 32344442560     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[167:TROAMI]2.0.CO;2     Document Type: Article

References (41)

1. Mair TS. Changing concepts of COPD. Equine Vet J 1995;27:402-403.
2. Moore BR. Lower respiratory tract disease. Vet Clin North Am Equine Pract 1996;12:457-472.
3. Robinson NE, Derksen FJ, Olszewski MA, et al. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 1996;152:283-306.
4. Lowell FC. Observations on heaves: An asthma-like syndrome in the horse. J Allergy Clin Immunol 1964;35:322-330.
5. Dixon PM, Railton DI, McGorum BC. Equine pulmonary disease - A case control study of 300 referred cases, Part 1: Examination techniques, diagnostic criteria and diagnoses. Equine Vet J 1995;27:416-421.
6. Derksen FJ, Robinson NE, Armstrong PJ, et al. Airway reactivity in ponies with recurrent airway obstruction (heaves). J Appl Physiol 1985;58:598-604.
7. Robinson NE, Olszewski MA, Boehler D, et al. Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine Vet J 2000;32:393-400.
8. Robinson NE, Berney C, Eberhart S, et al. Coughing, mucus accumulation, airway obstruction, and airway inflammation in control horses and horses affected with recurrent airway obstruction. Am J Vet Res 2003;64:550-557.
9. McGorum BC, Dixon PM. Evaluation of local endobronchial antigen challenges in the investigation of equine chronic obstructive pulmonary disease. Equine Vet J 1993;25:269-272.
10. McGorum BC, Ellison J, Cullen RT. Total and respirable airborne dust endotoxin concentrations in three equine management systems. Equine Vet J 1998;30:430-434.
11. Pirie RS, Dixon PM, Collie DD, et al. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Vet J 2001;33:311-318.
12. Pirie RS, Collie DD, Dixon PM, et al. Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clin Exp Allergy 2003;33:676-683.
13. Lavoie JP, Maghni K, Desnoyers M, et al. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med 2001;164:1410-1413.
14. Cordeau ME, Joubert P, Dewachi O, et al. IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves. Vet Immunol Immunopathol 2004;97:87-96.
15. Halliwell RE, Fleischman JB, Mackay-Smith M, et al. The role of allergy in chronic pulmonary disease of horses. J Am Vet Med Assoc 1979;174:277-281.
16. McGorum BC, Dixon PM, Halliwell RE. Quantification of histamine in plasma and pulmonary fluids from horses with chronic obstructive pulmonary disease, before and after 'natural (hay and straw) challenges'. Vet Immunol Immunopathol 1993;36:223-237.
17. Eder C, Crameri R, Mayer C, et al. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet Immunol Immunopathol 2000;73:241-253.
18. Ainsworth DM, Grunig G, Matychak MB, et al. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Vet Immunol Immunopathol 2003;96:83-91.
19. Giguere S, Viel L, Lee E, et al. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet Immunol Immunopathol 2002;85:147-158.
20. Franchini M, Gilli U, Akens MK, et al. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 1998;66:53-65.
21. Franchini M, Gill U, von Fellenberg R, et al. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am J Vet Res 2000;61:1369-1374.
22. Robinson NE. International Workshop on Equine Chronic Airway Disease. Michigan State University 16-18 June 2000. Equine Vet J 2001;33:5-19.
23. Pirie RS, Collie DD, Dixon PM, et al. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves, 2: Effects of inhaled HDS on control and heaves horses. Equine Vet J 2002;34:337-342.
24. Pirie RS, Dixon PM, McGorum BC. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 3: Effect of fractionation of HDS. Equine Vet J 2002;34:343-347.
25. Pirie RS, McLachlan G, McGorum BC. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves, 1: Preparation and composition of HDS. Equine Vet J 2002;34:332-336.
26. Nieuwstadt RA v. Muscarinic Receptor Subtypes on Equine Airway Smooth Muscle of Healthy Animals and Horses with Chronic Obstructive Pulmonary Disease. Utrecht, The Netherlands: Utrecht University; 1996, Thesis.
27. McGorum BC, Dixon PM, Halliwell RE, et al. Evaluation of urea and albumen as endogenous markers of dilution of equine bronchoalveolar lavage fluid. Res Vet Sci 1993;55:52-56.
28. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002;4:903-914.
29. Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: The role of cytokines. Curr Opin Infect Dis 2003;16:193-198.
30. Bureau F, Bonizzi G, Kirschvink N, et al. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 2000;161:1314-1321.
31. Alexis N, Eldridge M, Reed W, et al. CD14-dependent airway neutrophil response to inhaled LPS: Role of atopy. J Allergy Clin Immunol 2001;107:31-35.
32. Marr KA, Balajee SA, Hawn TR, et al. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun 2003;71:5280-5286.
33. Barton BE, Shortall J, Jackson JV. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun 1996;64:714-718.
34. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-1172.
35. Libert C, Takahashi N, Cauwels A, et al. Response of interleukin-6- deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur J Immunol 1994;24:2237-2242.
36. Xing Z, Gauldie J, Cox G, et al. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-320.
37. Izeboud CA, Mocking JA, Monshouwer M, et al. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res 1999;19:191-202.
38. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-550.
39. Marchant A, Bruyns C, Vandenabeele P, et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994;24:1167-1171.
40. Fernandez S, Jose P, Avdiushko MG, et al. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J Immunol 2004;172:2613-2620.
41. Virchow JC, Jr., Julius P, Matthys H, et al. CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. Eur Respir J 1998;11:317-323.